Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
CELLPROTEK Logo
CELLPROTEK Growth Score
60
CB Rank
315054
Heat Score
50
CELLPROTEK is a small molecule drug development company.
Founded
obfuscation
PublicPost-IPO Equity Guangzhou, Guangdong, China11-50 cellprotek.com
Consulting
Medical
Pharmaceutical
Overview

CELLPROTEK
Total Funding
obfuscation
Growth Score
60
Heat Score
50

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score60
-8 pts
in past quarter
Heat Score 50
-11 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About CELLPROTEK

CB Rank
315054
CELLPROTEK is a small molecule drug development company.
Founded
obfuscation
PublicPost-IPO Equity Guangzhou, Guangdong, China11-50 cellprotek.com
Consulting
Medical
Pharmaceutical

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation

Key People

Details

Also Known As 赛普特, 广州市赛普特医药科技股份有限公司, Saipute
Operating Status Active
Stock Symbol  NEEQ:835346
Company Type For Profit
About the Company
CELLPROTEK provides small molecule drugs for the treatment of major diseases of the central nervous system. They also create medications for acute ischemia stroke, alzheimer's disease, cardiovascular, cerebrovascular, and neurodegenerative diseases.
Phone Number 020-82258920
Contact Email gcp@cellprotek.com
Predictions & Insights

Products & Services

Annao Sanruo (YC-6) Injection
A small molecule drug injection for neuroprotection in acute ischemic stroke and other brain injuries.
Annao Sanruo (YC-6) Oral Formulation
An oral form of the YC-6 compound for neuroprotection and treatment of brain-related conditions.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - CELLPROTEK Logo
Post-IPO Equity - CELLPROTEK
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - CELLPROTEK Logo
Post-IPO Equity - CELLPROTEK
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - CELLPROTEK Logo
Post-IPO Equity - CELLPROTEK
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - CELLPROTEK Logo
Post-IPO Equity - CELLPROTEK
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - CELLPROTEK Logo
Post-IPO Equity - CELLPROTEK
—
obfuscation
— Post-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - CELLPROTEK Logo
Post-IPO Equity - CELLPROTEK
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - CELLPROTEK Logo
Post-IPO Equity - CELLPROTEK
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - CELLPROTEK Logo
Post-IPO Equity - CELLPROTEK
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - CELLPROTEK Logo
Post-IPO Equity - CELLPROTEK
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - CELLPROTEK Logo
Post-IPO Equity - CELLPROTEK
—
obfuscation
— Post-IPO Equity

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 1

Employee Profiles

News
Technology
View Tech Report

Monthly Web Visits

68

Active Website Tech Count

12CELLPROTEK is actively using 12 technologies for its website, according to BuiltWith. These include Viewport Meta, HSTS, and  Euro.
Sub-Organizations
Frequently Asked Questions

Where is CELLPROTEK's headquarters? CELLPROTEK is located in Guangzhou, Guangdong, China.When was the last funding round for CELLPROTEK? CELLPROTEK closed its last funding round on
obfuscation
from a Post-IPO Equity round.Who are CELLPROTEK's competitors? Alternatives and possible competitors to CELLPROTEK may include Tenvie Therapeutics, NeuroDawn Pharmaceutical, and  Kangdesai Medical Technology.How much funding has CELLPROTEK raised to date? CELLPROTEK has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(8fe006b 1)
|